Abstract

Although dual-energy X-ray absorptiometry (DXA) and body impedance analysis are commonly used to measure skeletal muscle mass (SMM), a computed tomography (CT) scan is preferred in clinical practice. We aimed to propose the cut-off values of skeletal muscle mass index (SMI) calculated using CT scans, using DXA as the reference method. We retrospectively assessed 589 patients with chronic liver disease. The SMI was assessed using appendicular SMM by DXA and total muscle area at the level of the third lumbar vertebra (L3) calculated by CT. The cut-off value was determined with reference to the Asian Working Group for Sarcopenia criteria. DXA identified 251 (42.6%) patients as having presarcopenia. In men, the cut-off value of SMI for presarcopenia was determined to be 45.471 cm2/m2, with an area under the curve (AUC) of 0.863 (95% confidence interval (CI): 0.823 to 0.903), and in women, this value was determined to be 35.170 cm2/m2, with an AUC of 0.846 (95% CI: 0.800 to 0.892). Cohen’s kappa coefficient was 0.575 (95% CI: 0.485–0.665) in men and 0.539 (95% CI: 0.438–0.639) in women.

Highlights

  • Sarcopenia, defined as decreases in muscle mass, strength, and physical function, is an important cause of functional decline associated with aging and chronic illness [1,2,3].Presarcopenia is defined as the loss of muscle mass by European Working on Sarcopenia inOlder People [2]

  • We found that 251 (42.6%) patients were diagnosed with presarcopenia according to Asian Working Group for Sarcopenia (AWGS) criteria

  • The present study enhances the validity of computed tomography (CT)-based sarcopenia diagnosis in patients with chronic liver disease (CLD)

Read more

Summary

Introduction

This condition can negatively influence clinical outcomes in patients with chronic liver disease (CLD) [4,5,6]. In. 2016, the Japanese Society of Hepatology (JSH) published diagnostic criteria for sarcopenia suitable for use in patients with liver disease [10]. 2016, the Japanese Society of Hepatology (JSH) published diagnostic criteria for sarcopenia suitable for use in patients with liver disease [10] These criteria diagnose sarcopenia based on grip strength and skeletal muscle mass index (SMI). The grip strength cut-off values are

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.